All

Results: 34129-34140 of 60355

UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024

PR Newswire associated0

Newly-Released "BIG BANK": An Excellent Battery System for Commercial Vehicles

Co-Founder OF Leading Think Tank Unveils Radical Free-Market Policies For A Better Britain

PR Newswire associated0

HUAWEI Innovative Product Launch Unveils Next-Gen Wearables Experience and Seamless Productivity with Tablets

The parable of the lost sheep mirrors our journey to find a solution for Duchenne Muscular Dystrophy (DMD), a rare disease. Our global interdisciplinary team is fortunate to have been gifted with Neu REFIX, whose hidden potentials of beneficial immune modulation, we unravelled by extensive preclinical and clinical studies. This gives hope to DMD patients for its potentials in improving their quality of life by halting the disease progress. Like the shepherd when he found the lost sheep, our joy knew no bounds, when we got encouraging outcome in DMD research. Now on receiving orphan drug and rare paediatric disease designations from US FDA, while it’s time to rejoice, we have miles to go until it reaches every deserving patient after an approval, the final goal. We are open to collaborate with likeminded institutes to reach the goal. Further insights have revealed the potentials of Neu REFIX in Psoriasis, auto-immune diseases and in Multiple Sclerosis by gut microbiome reconstitution. (Graphic: Business Wire)

Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy

EDITORIAL USE ONLY Heathrow Express Learning Linguistics - Edit. Picture date: Thursday August 29, 2024. PA Photo.

Need To Brush Up On Your Spanish? You’re Not Alone: Nearly Half Of Brits Admit To Not Speaking The Local Language When Abroad

PR Newswire associated0

AG&P Industrial creates history by setting sail its first-ever module shipment to Europe, in Antwerp, Belgium for INEOS's over € 4 Billion landmark Project ONE

PR Newswire associated0

Niutech at the Forefront: U.S.-China Circular Economy Forum Tackles "White Pollution"

PR Newswire associated0

UK & European Small-Business Owners Take CoCo Bubble Tea to New Heights

Valmet to supply a new BCTMP line and an evaporator line to JK Paper Limited in India

GlobeNewswire associated0

Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users

Bioretec's Shareholders' Nomination Board appointed